Anderson Raymond has filed 14 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 2924 shares of Monopar Therapeutics ($MNPR) on December 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | A | Stock Options | 2924 | $0.00 | 2,924.0000 | 6,662,930 | 9999.99% | 0.04% |
| March 4, 2025 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | A | Stock Options | 11365 | $0.00 | 11,365.0000 | 6,102,560 | 9999.99% | 0.19% |
| Dec. 31, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Restricted Stock Units | 2533 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 31, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Common Stock | 2533 | $0.00 | 26,863.0000 | 0 | 10.41% | 0.00% |
| Sept. 30, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Restricted Stock Units | 2533 | $0.00 | 2,533.0000 | 0 | 50.00% | 0.00% |
| Sept. 30, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Common Stock | 2533 | $0.00 | 24,330.0000 | 0 | 11.62% | 0.00% |
| June 30, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Restricted Stock Units | 2534 | $0.00 | 5,066.0000 | 0 | 33.34% | 0.00% |
| June 30, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Common Stock | 2534 | $0.00 | 21,797.0000 | 0 | 13.15% | 0.00% |
| March 31, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Restricted Stock Units | 2533 | $0.00 | 7,600.0000 | 0 | 25.00% | 0.00% |
| March 31, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Common Stock | 2533 | $0.00 | 19,263.0000 | 0 | 15.14% | 0.00% |
| Feb. 1, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | A | Stock Options | 13930 | $0.00 | 13,930.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | A | Restricted Stock Units | 10133 | $0.00 | 10,133.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2022 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Common Stock | 2859 | $0.00 | 16,730.0000 | 0 | 20.61% | 0.00% |
| Dec. 31, 2022 | Monopar Therapeutics | $MNPR | Anderson Raymond | Director | M | Restricted Stock Units | 2859 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |